The synthesis of tirzepatide was initial disclosed in patents submitted by Eli Lilly and Firm in 2016.[36] This utilizes common stable phase peptide synthesis, with an allyloxycarbonyl safeguarding team over the lysine at position 20 of the linear chain of amino acids, making it possible for a closing list https://corepepptides.com/product/tirzepatide-10mg/